Targeting the disrupted Hippo signaling to prevent neoplastic renal epithelial cell immune evasion
2025 · Nature Communications · 8 citations
https://doi.org/10.1038/s41467-025-57697-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
208
Citations
8
h-index
6
i10-index
Jiyuan Liu is an academic researcher from Harvard University. The author has contributed to research in topics: Hippo pathway signaling and YAP/TAZ & Phytochemicals and Antioxidant Activities & Microtubule and mitosis dynamics. The author has an h-index of 8, co-authored 12 publications.
ORCID: 0000-0002-0372-4106https://doi.org/10.1038/s41467-025-57697-7
https://doi.org/10.1038/s44319-024-00233-3
Click to start Chat